{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:31:35Z","timestamp":1791070295296,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T00:00:00Z","timestamp":1374192000000},"content-version":"vor","delay-in-days":3944,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Human Genetics"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1086\/342716","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T16:15:19Z","timestamp":1034093719000},"page":"715-723","source":"Crossref","is-referenced-by-count":203,"title":["Predictors of the Risk of Mortality in Neurofibromatosis 2"],"prefix":"10.1016","volume":"71","author":[{"given":"Michael E.","family":"Baser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Aeschliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Joe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Ramsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gareth R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1086\/342716_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.54.1.71","article-title":"Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas","volume":"54","author":"Antinheimo","year":"2000","journal-title":"Neurology"},{"issue":"Suppl 65","key":"10.1086\/342716_bib3","first-page":"A61","article-title":"Predictors of survival in neurofibromatosis","author":"Baser","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1086\/342716_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/jns.2002.96.2.0217","article-title":"Predictors of vestibular Schwannoma growth in patients with neurofibromatosis type 2","volume":"96","author":"Baser","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1086\/342716_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1096-8628(19960906)64:4<563::AID-AJMG7>3.0.CO;2-Q","article-title":"Phenotypic variability in monozygotic twins with neurofibromatosis 2","volume":"64","author":"Baser","year":"1996","journal-title":"Am J Med Genet"},{"key":"10.1086\/342716_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<184::AID-GCC15>3.0.CO;2-B","article-title":"Severe phenotype of the neurofibromatosis type 2 gene in patients with a 7.4 Mbp constitutional deletion on chromosome 22: possible localization of a neurofibromatosis type 2 modifier gene?","volume":"25","author":"Bruder","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1086\/342716_bib7","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1007\/s004390050978","article-title":"A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene","volume":"104","author":"Bruder","year":"1999","journal-title":"Hum Genet"},{"key":"10.1086\/342716_bib8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/00005537-199611000-00019","article-title":"The learning curve for acoustic tumor surgery","volume":"106","author":"Buchman","year":"1996","journal-title":"Laryngoscope"},{"key":"10.1086\/342716_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3109\/00016489209137478","article-title":"Suboccipital acoustic neuroma surgery: results of decentralized neurosurgical tumor removal in Denmark","volume":"112","author":"Charabi","year":"1992","journal-title":"Acta Otolaryngol"},{"key":"10.1086\/342716_bib10","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jmg.37.12.897","article-title":"Neurofibromatosis type 2","volume":"37","author":"Evans","year":"2000","journal-title":"J Med Genet"},{"key":"10.1086\/342716_bib11","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans","year":"1992","journal-title":"Q J Med"},{"key":"10.1086\/342716_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/jmg.29.12.841","article-title":"A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity","volume":"29","author":"Evans","year":"1992","journal-title":"J Med Genet"},{"key":"10.1086\/342716_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S002221510012328X","article-title":"Type 2 neurofibromatosis: the need for supraregional care?","volume":"107","author":"Evans","year":"1993","journal-title":"J Laryngol Otol"},{"key":"10.1086\/342716_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.35.6.450","article-title":"Genotype\/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations","volume":"35","author":"Evans","year":"1998","journal-title":"J Med Genet"},{"key":"10.1086\/342716_bib15","first-page":"727","article-title":"Somatic mosaicism: a common cause of classic disease in tumor-prone syndromes? lessons from type 2 neurofibromatosis","volume":"63","author":"Evans","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1086\/342716_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/hmg\/7.3.335","article-title":"Defects in neurofibromatosis 2 protein function can arise at multiple levels","volume":"7","author":"Gutmann","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1086\/342716_bib17","first-page":"691","article-title":"The perils of decentralized care in otology\/neuro-otology","volume":"19","author":"Jackler","year":"1998","journal-title":"Am J Otol"},{"key":"10.1086\/342716_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-2443.2001.00432.x","article-title":"Identification of the cis-acting region in the NF2 gene promoter as a potential target for mutation and methylation-dependent silencing in schwannoma","volume":"6","author":"Kino","year":"2001","journal-title":"Genes Cells"},{"key":"10.1086\/342716_bib19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s004390050255","article-title":"Identification of NF2 germ-line mutations and comparison with NF2 phenotypes","volume":"98","author":"Kluwe","year":"1996","journal-title":"Hum Genet"},{"key":"10.1086\/342716_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1096-8628(19980518)77:3<228::AID-AJMG8>3.0.CO;2-L","article-title":"Phenotypic variability associated with 14 splice-site mutations in the NF2 gene","volume":"77","author":"Kluwe","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1086\/342716_bib21","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/hmg\/7.13.2051","article-title":"Mosaicism in sporadic neurofibromatosis 2 patients","volume":"7","author":"Kluwe","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1086\/342716_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1071-9091(98)80003-X","article-title":"The diagnosis and management of neurofibromatosis 2 in childhood","volume":"5","author":"MacCollin","year":"1998","journal-title":"Semin Pediatr Neurol"},{"key":"10.1086\/342716_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3171\/jns.2002.96.2.0223","article-title":"Vestibular schwannoma growth in patients with neurofibromatosis type 2: a longitudinal study","volume":"96","author":"Mautner","year":"2002","journal-title":"J Neurosurg"},{"key":"10.1086\/342716_bib24","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00006123-199605000-00004","article-title":"The neuroimaging and clinical spectrum of neurofibromatosis 2","volume":"38","author":"Mautner","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1086\/342716_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1227\/00006123-199307000-00014","article-title":"Neurofibromatosis 2 in the pediatric age group","volume":"33","author":"Mautner","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1086\/342716_bib26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2214\/ajr.165.4.7676998","article-title":"Spinal tumors in patients with neurofibromatosis type 2: MR imaging study of frequency, multiplicity, and variety","volume":"165","author":"Mautner","year":"1995","journal-title":"AJR Am J Roentgenol"},{"key":"10.1086\/342716_bib27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3171\/jns.1998.88.5.0831","article-title":"Factors associated with survival in patients with meningioma","volume":"88","author":"McCarthy","year":"1998","journal-title":"J Neurosurg"},{"key":"10.1086\/342716_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/gcc.2870120206","article-title":"Screening for germ-line mutations in the NF2 gene","volume":"12","author":"M\u00e9rel","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1086\/342716_bib29","series-title":"Data analysis and regression: a second course in statistics","author":"Mosteller","year":"1977"},{"key":"10.1086\/342716_bib30","first-page":"486","article-title":"Neurofibromatosis type 2 appears to be a genetically homogeneous disease","volume":"51","author":"Narod","year":"1992","journal-title":"Am J Hum Genet"},{"key":"10.1086\/342716_bib31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity","volume":"52","author":"Parry","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1086\/342716_bib32","first-page":"529","article-title":"Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities","volume":"59","author":"Parry","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1086\/342716_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau","year":"1993","journal-title":"Nature"},{"key":"10.1086\/342716_bib34","first-page":"331","article-title":"Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease","volume":"59","author":"Ruttledge","year":"1996","journal-title":"Am J Hum Genet"},{"key":"10.1086\/342716_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng0498-354","article-title":"Neurofibromatosis 2 tumour suppressor schwannomin interacts with \u03b2II-spectrin","volume":"18","author":"Scoles","year":"1998","journal-title":"Nat Genet"},{"key":"10.1086\/342716_bib36","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0092-8674(93)90406-G","article-title":"A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor","volume":"72","author":"Trofatter","year":"1993","journal-title":"Cell"},{"key":"10.1086\/342716_bib37","series-title":"Modern applied statistics with S-Plus","author":"Venables","year":"1997"},{"key":"10.1086\/342716_bib38","first-page":"644","article-title":"The learning curve in vestibular schwannoma surgery","volume":"20","author":"Welling","year":"1999","journal-title":"Am J Otol"},{"key":"10.1086\/342716_bib39","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/hmg\/7.13.2095","article-title":"NF2 gene in neurofibromatosis type 2 patients","volume":"7","author":"Zucman-Rossi","year":"1998","journal-title":"Hum Mol Genet"}],"container-title":["The American Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707603590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002929707603590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T13:26:15Z","timestamp":1554729975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002929707603590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0002929707603590"],"URL":"https:\/\/doi.org\/10.1086\/342716","relation":{},"ISSN":["0002-9297"],"issn-type":[{"value":"0002-9297","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}